Advanced search
Publication Cover
Climacteric Volume 16, 2013 - Issue 3
Submit an article Journal homepage
2,592
Views
220
CrossRef citations to date
0
Altmetric
RECOMMENDATIONS

Updated 2013 International Menopause Society recommendations on menopausal hormone therapy and preventive strategies for midlife health

T. J. de VilliersMediClinic Panorama and Department of Obstetrics and Gynecology, Stellenbosch University, Cape Town, South Africa
,
A. Pines *Sackler Faculty of Medicine, Tel-Aviv University, Tel-Aviv, Israel
,
N. PanayQueen Charlotte's & Chelsea Hospital, and Chelsea and Westminster Hospital, London, UK
,
M. GambaccianiDepartment of Obstetrics and Gynecology, Pisa University Hospital, Pisa, Italy
,
D. F. ArcherJones Institute, Eastern Virginia Medical School, Norfolk, VA, USA
,
R. J. BaberSydney Medical School, The University of Sydney, NSW, Australia
,
S. R. DavisDepartment of Epidemiology and Preventive Medicine, School of Public Health and Preventive Medicine, Monash University, Melbourne, Victoria, Australia
,
A. A. GompelUF de Gynécologie, Université Paris Descartes, AP-HP, Hôtel-Dieu, Paris, France
,
V. W. HendersonDepartments of Health Research & Policy (Epidemiology) and of Neurology & Neurological Sciences, Stanford University, Stanford, CA, USA
,
R. LangerAssociate Dean for Clinical and Translational Research and Professor of Family Medicine-Las Vegas, University of Nevada School of Medicine, Las Vegas, NV, USA
,
R. A. LoboDepartment of Obstetrics and Gynecology, Columbia University, New York, NY, USA
,
G. Plu-BureauUnité de Gynécologie Médicale, Hôtel Dieu, Paris, France
,
D. W. SturdeeHeart of England NHS Foundation Trust, Solihull Hospital, Birmingham, UK
& on behalf of the International Menopause Society show all
Pages 316-337 | Published online: 15 May 2013

Citations (220)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (63)

Serge Rozenberg, Nick Panay, Marco Gambacciani, Antonio Cano, Sarah Gray & Katrin Schaudig. (2023) Breaking down barriers for prescribing and using hormone therapy for the treatment of menopausal symptoms: an experts’ perspective. Expert Review of Clinical Pharmacology 16:6, pages 507-517.
Read now
Paru S David, Taryn L Smith, Hannah C Nordhues & Juliana M Kling. (2022) A Clinical Review on Paroxetine and Emerging Therapies for the Treatment of Vasomotor Symptoms. International Journal of Women's Health 14, pages 353-361.
Read now
S. Gasser, K. Heidemeyer, M. von Wolff & P. Stute. (2021) Impact of progesterone on skin and hair in menopause – a comprehensive review. Climacteric 24:3, pages 229-235.
Read now
W.J. Gou, J.Z. Zhao, R. Zhang, T. Yang, L.Y. Wang & X.H. Zhang. (2019) A menopause survey of women with benign breast disease history in northwest China. Climacteric 22:6, pages 622-626.
Read now
R. B. Natari, T. M. McGuire, P. J. Baker, A. M. Clavarino, K. D. Dingle & S. A. Hollingworth. (2019) Longitudinal impact of the Women’s Health Initiative study on hormone therapy use in Australia. Climacteric 22:5, pages 489-497.
Read now
Zeinab Javadivala, Effat Merghati-Khoei, Mohammad Asghari Jafarabadi, Hamid Allahverdipour, Mojgan Mirghafourvand, Haidar Nadrian & Kamiar Kouzekanani. (2019) Efficacy of pharmacological and non-pharmacological interventions on low sexual interest/arousal of peri- and post-menopausal women: a meta-analysis. Sexual and Relationship Therapy 34:2, pages 242-270.
Read now
A. Coquoz, C. Gruetter & P. Stute. (2019) Impact of micronized progesterone on body weight, body mass index, and glucose metabolism: a systematic review. Climacteric 22:2, pages 148-161.
Read now
Placido Llaneza, Joaquim Calaf, Ana Rosa Jurado, Nicolas Mendoza, Borja Otero, Francisco Quereda, Rafael Sánchez-Borrego & Daniel Lubian. (2018) What do TSECs provide in the menopausal hormone therapy?. Gynecological Endocrinology 34:10, pages 826-832.
Read now
Irina Virtanen, Nea Kalleinen, Anna S. Urrila & Päivi Polo-Kantola. (2018) First-Night Effect on Sleep in Different Female Reproductive States. Behavioral Sleep Medicine 16:5, pages 437-447.
Read now
T. J. de Villiers. (2018) Should women be screened for osteoporosis at midlife?. Climacteric 21:3, pages 239-242.
Read now
P. Stute, L. Wildt & J. Neulen. (2018) The impact of micronized progesterone on breast cancer risk: a systematic review. Climacteric 21:2, pages 111-122.
Read now
G. P. Siliquini, V. Tuninetti, V. E. Bounous, F. Bert & N. Biglia. (2017) Fractional CO2 laser therapy: a new challenge for vulvovaginal atrophy in postmenopausal women. Climacteric 20:4, pages 379-384.
Read now
L. Yeganeh, J. Boyle, H. Teede & A. Vincent. (2017) Knowledge and attitudes of health professionals regarding menopausal hormone therapies. Climacteric 20:4, pages 348-355.
Read now
Kerstin Weidner, Ilona Croy, Timo Siepmann, Elmar Brähler, Manfred Beutel & Antje Bittner. (2017) Menopausal syndrome limited to hot flushes and sweating a representative survey study. Journal of Psychosomatic Obstetrics & Gynecology 38:3, pages 170-179.
Read now
J. Aleksova, M. Kuczynska-Burggraf, S. Ranasinha & A. Vincent. (2017) Information on early menopause: is the internet the place to search?. Climacteric 20:3, pages 248-255.
Read now
Sharon J. Parish & John A. Gillespie. (2017) The evolving role of oral hormonal therapies and review of conjugated estrogens/bazedoxifene for the management of menopausal symptoms. Postgraduate Medicine 129:3, pages 340-351.
Read now
Risa Kagan, Steven R Goldstein, James H Pickar & Barry S Komm. (2016) Patient considerations in the management of menopausal symptoms: role of conjugated estrogens with bazedoxifene. Therapeutics and Clinical Risk Management 12, pages 549-562.
Read now
Santiago Palacios & Andrea Mejía. (2016) Progestogen safety and tolerance in hormonal replacement therapy. Expert Opinion on Drug Safety 15:11, pages 1515-1525.
Read now
Manuel Cortés-Bonilla, Rosalba Alonso-Campero, Roberto Bernardo-Escudero, María T. Francisco-Doce, Juan Chavarín-González, Ricardo Pérez-Cuevas & Peter Chedraui. (2016) Improvement of quality of life and menopausal symptoms in climacteric women treated with low-dose monthly parenteral formulations of non-polymeric microspheres of 17β-estradiol/progesterone. Gynecological Endocrinology 32:10, pages 831-834.
Read now
M. Kalder, I. Kyvernitakis, O. Hars, A. Kauka & P. Hadji. (2016) Comparison of combined low-dose hormone therapy vs. tibolone in the prevention of bone loss. Climacteric 19:5, pages 471-477.
Read now
P. Stute, J. Neulen & L. Wildt. (2016) The impact of micronized progesterone on the endometrium: a systematic review. Climacteric 19:4, pages 316-328.
Read now
J. J. von Holzen, G. Capaldo, M. Wilhelm & P. Stute. (2016) Impact of endo- and exogenous estrogens on heart rate variability in women: a review. Climacteric 19:3, pages 222-228.
Read now
J. H. Pickar, J. M. Amadio, B. A. Bernick & S. Mirkin. (2016) Pharmacokinetic studies of solubilized estradiol given vaginally in a novel softgel capsule. Climacteric 19:2, pages 181-187.
Read now
R. J. Baber, N. Panay & A. Fenton$suffix/text()$suffix/text(). (2016) 2016 IMS Recommendations on women’s midlife health and menopause hormone therapy. Climacteric 19:2, pages 109-150.
Read now
Dana G Carroll, Katelin M Lisenby & Tracy L Carter. (2015) Critical appraisal of paroxetine for the treatment of vasomotor symptoms. International Journal of Women's Health 7, pages 615-624.
Read now
T. J. de Villiers. (2015) The role of menopausal hormone therapy in the management of osteoporosis. Climacteric 18:sup2, pages 19-21.
Read now
I. Kyvernitakis, K. Kostev, O. Hars, U-S. Albert, M. Kalder & P. Hadji. (2015) Persistency with estrogen replacement therapy among hysterectomized women after the Women’s Health Initiative study. Climacteric 18:6, pages 826-834.
Read now
S. Palacios, L. Kalouche-Khalil, R. Rizzoli, C. Zapalowski, H. Resch, J. D. Adachi, J. C. Gallagher, R. G. Feldman, D. L. Kendler, A. Wang, R. B. Wagman & S. Adami. (2015) Treatment with denosumab reduces secondary fracture risk in women with postmenopausal osteoporosis. Climacteric 18:6, pages 805-812.
Read now
M. Gambacciani, M. G. Torelli, L. Martella, G. L. Bracco, A. G. Casagrande, E. Albertin, S. Tabanelli, M. Viglietta, G. D’Ambrogio, G. Garone & M. Cervigni. (2015) Rationale and design for the Vaginal Erbium Laser Academy Study (VELAS): an international multicenter observational study on genitourinary syndrome of menopause and stress urinary incontinence. Climacteric 18:sup1, pages 43-48.
Read now
Nick Panay & Anna Fenton. (2015) New guidelines – new hope?. Climacteric 18:5, pages 661-662.
Read now
P. Lehert, P. Villaseca, E. Hogervorst, P. M. Maki & V. W. Henderson. (2015) Individually modifiable risk factors to ameliorate cognitive aging: a systematic review and meta-analysis. Climacteric 18:5, pages 678-689.
Read now
E. Boschitsch. (2015) For how long should osteoporosis treatment continue?. Climacteric 18:5, pages 675-677.
Read now
M. Gambacciani, M. Levancini & M. Cervigni. (2015) Vaginal erbium laser: the second-generation thermotherapy for the genitourinary syndrome of menopause. Climacteric 18:5, pages 757-763.
Read now
I. Kyvernitakis, K. Kostev, O. Hars, U-s. Albert & P. Hadji. (2015) Discontinuation rates of menopausal hormone therapy among postmenopausal women in the post-WHI study era. Climacteric 18:5, pages 737-742.
Read now
A. J. Vincent. (2015) Management of menopause in women with breast cancer. Climacteric 18:5, pages 690-701.
Read now
K. Jiang, Y. Jin, L. Huang, S. Feng, X. Hou, B. Du, J. Zheng & L. Li. (2015) Black cohosh improves objective sleep in postmenopausal women with sleep disturbance. Climacteric 18:4, pages 559-567.
Read now
C. Gerlinger, K. Gude, T. Schmelter, M. Schaefers & J. Endrikat. (2015) 0.5 vs. 1.0 mg estradiol in combination with drospirenone for the treatment of hot flushes. Climacteric 18:4, pages 512-517.
Read now
P. Vichinsartvichai, C. Manolertthewan & P. Promrungrueng. (2015) Premature ovarian failure with 46,XX,t(1;4)(p34.1;q34): first case report and literature review. Climacteric 18:4, pages 656-658.
Read now
Daniela Rouskova, Katrin Mittmann, Ulrike Schumacher, Horst Dietrich & Thomas Zimmermann. (2015) Effectiveness, tolerability and acceptance of a low-dosed estradiol/dienogest formulation (Lafamme 1 mg/2 mg) for the treatment of menopausal complaints: a non-interventional observational study over 6 cycles of 28 days. Gynecological Endocrinology 31:7, pages 560-564.
Read now
Manuel Cortés-Bonilla, Roberto Bernardo-Escudero, Rosalba Alonso-Campero, María T. Francisco-Doce, Marcelino Hernández-Valencia, Cuauhtémoc Celis-González, Ricardo Márquez-Oñate, Peter Chedraui & Juan A. Uribe. (2015) Treatment of menopausal symptoms with three low-dose continuous sequential 17β-estradiol/progesterone parenteral monthly formulations using novel non-polymeric microsphere technology. Gynecological Endocrinology 31:7, pages 552-559.
Read now
J. Wactawski-Wende & G. L. Anderson. (2015) Of conflicts, conspiracies, red herrings, and black swans. Climacteric 18:3, pages 343-345.
Read now
Rossella E Nappi & Laura Cucinella. (2015) Advances in pharmacotherapy for treating female sexual dysfunction. Expert Opinion on Pharmacotherapy 16:6, pages 875-887.
Read now
M. Li, A. Wang, L. Hu, Z. Song, Y. Zhao, Y. Sun, L. Yan & X. Li. (2015) Effects of estradiol–drospirenone on menopausal symptoms, lipids and bone turnover in Chinese women. Climacteric 18:2, pages 214-218.
Read now
P. Stute, H.-G. Becker, J. Bitzer, D. Chatsiproios, F. Luzuy, M. von Wolff, D. Wunder & M. Birkhäuser. (2015) Ultra-low dose – new approaches in menopausal hormone therapy. Climacteric 18:2, pages 182-186.
Read now
S. Salvatore, R. E. Nappi, M. Parma, R. Chionna, F. Lagona, N. Zerbinati, S. Ferrero, M. Origoni, M. Candiani & U. Leone Roberti Maggiore. (2015) Sexual function after fractional microablative CO2 laser in women with vulvovaginal atrophy. Climacteric 18:2, pages 219-225.
Read now
Stephanie S Faubion, Ekta Kapoor, Carol L Kuhle, Richa Sood, Jacqueline M Thielen & Virginia M Miller. (2015) Recommendations for hormone therapy in hysterectomized women: importance of new data in clinical management. Expert Review of Endocrinology & Metabolism 10:1, pages 55-63.
Read now
Richa Sood, Stephanie S Faubion, Carol L Kuhle, Jacqueline M Thielen & Lynne T Shuster. (2014) Prescribing menopausal hormone therapy: an evidence-based approach. International Journal of Women's Health 6, pages 47-57.
Read now
Amos Pines. (2014) Climacteric commentaries. Climacteric 17:6, pages 721-728.
Read now
P.-Y. Scarabin. (2014) Hormones and venous thromboembolism among postmenopausal women. Climacteric 17:sup2, pages 34-37.
Read now
R. A. Lobo. (2014) What the future holds for women after menopause: where we have been, where we are, and where we want to go. Climacteric 17:sup2, pages 12-17.
Read now
V. W. Henderson. (2014) Three midlife strategies to prevent cognitive impairment due to Alzheimer's disease. Climacteric 17:sup2, pages 38-46.
Read now
R. A. Lobo, S. R. Davis, T. J. De Villiers, A. Gompel, V. W. Henderson, H. N. Hodis, M. A. Lumsden, W. J. Mack, S. Shapiro & R. J. Baber. (2014) Prevention of diseases after menopause. Climacteric 17:5, pages 540-556.
Read now
F. M. Jane & S. R. Davis. (2014) A Practitioner's Toolkit for Managing the Menopause. Climacteric 17:5, pages 564-579.
Read now
Amos Pines. (2014) Climacteric commentaries. Climacteric 17:4, pages 510-516.
Read now
S. Salvatore, R. E. Nappi, N. Zerbinati, A. Calligaro, S. Ferrero, M. Origoni, M. Candiani & U. Leone Roberti Maggiore. (2014) A 12-week treatment with fractional CO2 laser for vulvovaginal atrophy: a pilot study. Climacteric 17:4, pages 363-369.
Read now
Nick Panay & Anna Fenton. (2014) The ‘window of opportunity’ – should we be taking it?. Climacteric 17:3, pages 211-212.
Read now
Rod Baber. (2014) On aspirations. Climacteric 17:3, pages 213-214.
Read now
R. E. Nappi & S. Palacios. (2014) Impact of vulvovaginal atrophy on sexual health and quality of life at postmenopause. Climacteric 17:1, pages 3-9.
Read now
Sebastian Mirkin, Barry S Komm & James H Pickar. (2014) Conjugated estrogens for the treatment of menopausal symptoms: a review of safety data. Expert Opinion on Drug Safety 13:1, pages 45-56.
Read now
Amos Pines. (2013) Climacteric Commentaries. Climacteric 16:6, pages 718-728.
Read now
Nick Panay & Anna Fenton. (2013) Advances in menopause research – what does the next decade hold?. Climacteric 16:sup1, pages 3-4.
Read now
Anna Fenton & Nick Panay. (2013) Menopause – quantifying the cost of symptoms. Climacteric 16:4, pages 405-406.
Read now
M. L’Hermite. (2013) HRT optimization, using transdermal estradiol plus micronized progesterone, a safer HRT. Climacteric 16:sup1, pages 44-53.
Read now

Articles from other publishers (157)

Tayebeh Darooneh, Vida Ghasemi, Nasibeh Roozbeh, Behzad Mohammadsouri, Fatemeh Darsareh, Vahid Mehrnoush, Leila Mohamad-Khani Shahri & Mojdeh Banaei. (2023) The effect of vitamin D on sexual function: a systematic review. Nutrire 48:2.
Crossref
Rachel E. Duke, Nicholas J. Stanich, Sivanandane Sittadjody, Emmanuel C. Opara, Jason A. Berberich & Justin M. Saul. (2023) A Simple Mathematical Model Demonstrates the Potential for Cell-Based Hormone Therapy to Address Dysregulation of the Hypothalamus-Pituitary-Ovary Axis in Females with Loss of Ovarian Function. Annals of Biomedical Engineering.
Crossref
Zinat Sarebani, Venus Chegini, Hui Chen, Ehsan Aali, Monirsadat Mirzadeh, Mohammadreza Abbaspour, Mark D. Griffiths & Zainab Alimoradi. (2023) Effect of vitamin D vaginal suppository on sexual functioning among postmenopausal women: A three-arm randomized controlled clinical trial. Obstetrics & Gynecology Science 66:3, pages 208-220.
Crossref
Leslie Cho, Andrew M. KaunitzStephanie S. FaubionSharonne N. Hayes, Emily S. Lau, Nicole PristeraNandita Scott, Jan L. ShifrenChrisandra L. Shufelt, Cynthia A. StuenkelKathryn J. Lindley. (2023) Rethinking Menopausal Hormone Therapy: For Whom, What, When, and How Long?. Circulation 147:7, pages 597-610.
Crossref
莹莹 范. (2023) Current Status of MHT Treatment for Menopausal Syndrome. Advances in Clinical Medicine 13:04, pages 5396-5400.
Crossref
Akanksha Goyal, Pratima Gupta & David W. Sturdee. 2023. Reference Module in Biomedical Sciences. Reference Module in Biomedical Sciences.
Ye Zhu, Junxiu Wei, Xin Yang, Wei Zhu & Weiting Zhang. (2022) Investigation on prevalence and risk factors associated with genitourinary syndrome of menopause in middle-aged and older women in Beijing community: a cross sectional study. BMC Women's Health 22:1.
Crossref
Tobias De Villiers. (2022) The management of vasomotor symptoms of menopause (VMS) with menopausal hormone therapy (MHT). Current Opinion in Endocrine and Metabolic Research 27, pages 100420.
Crossref
V.O. Benyuk, V.V. Kurochka, V.F. Oleshko & A.A. Momot. (2022) Modern integrated approach in the treatment of atrophic vaginitis in women of menopausal age. Reproductive health of woman:5, pages 51-56.
Crossref
Doaa M. Saleh & Rania Abdelghani. (2022) Clinical evaluation of autologous platelet rich plasma injection in postmenopausal vulvovaginal atrophy: A pilot study. Journal of Cosmetic Dermatology 21:10, pages 4269-4275.
Crossref
L. Yu. Karakhalis. (2022) Correction of menopausal disorders: new possibilities of menopausal hormone therapy. Meditsinskiy sovet = Medical Council:5, pages 112-116.
Crossref
Maria Alejandra Belardo, Pisula Pedro & Capalbo Olivia. (2022) Breast cancer and progestins in menopausal hormone therapy: a literature review. Obstetrics & Gynecology International Journal 13:2, pages 101-110.
Crossref
Daniel María Lubián López. (2022) Management of genitourinary syndrome of menopause in breast cancer survivors: An update. World Journal of Clinical Oncology 13:2, pages 71-100.
Crossref
T. M. Sokolova, I. O. Marinkin, K. Yu. Makarov, V. M. Kuleshov, T. V. Kiselyova, A. V. Yakimov, I. M. Pozdnyakov & S. Yu. Yuriev. (2021) 17β-Estradiol, Drosperinone, and UDCA Effective in Cholestasis in Early Postmenopausal Syndrome. Experimental and Clinical Gastroenterology:7, pages 23-29.
Crossref
Sebastian Mirkin, James A. Simon, James H. Liu, David F. Archer, Patricia D. Castro, Shelli Graham, Brian Bernick & Barry Komm. (2021) Evaluation of endometrial progesterone receptor expression after 12 weeks of exposure to a low-dose vaginal estradiol insert. Menopause 28:9, pages 998-1003.
Crossref
Alison K. Shea, Alice Buwembo, Alexandra MayhewNazmul SohelLauren E. GriffithParminder Raina. (2021) The association between primary ovarian insufficiency and osteoporosis in the Canadian Longitudinal Study on Aging. Menopause 28:6, pages 693-698.
Crossref
Jason Cruff & Salil Khandwala. (2021) A Double-Blind Randomized Sham-Controlled Trial to Evaluate the Efficacy of Fractional Carbon Dioxide Laser Therapy on Genitourinary Syndrome of Menopause. The Journal of Sexual Medicine 18:4, pages 761-769.
Crossref
Vera E. Balan, Elena V. Tikhomirova, Anastasia S. Zhuravel, Julia P. Titchenko & Tatyana V. Lovygina. (2021) New trends in current menopausal hormone therapy. Gynecology 23:1, pages 33-36.
Crossref
Angela H E M Maas, Giuseppe Rosano, Renata Cifkova, Alaide Chieffo, Dorenda van Dijken, Haitham Hamoda, Vijay Kunadian, Ellen Laan, Irene Lambrinoudaki, Kate Maclaran, Nick Panay, John C Stevenson, Mick van Trotsenburg & Peter Collins. (2021) Cardiovascular health after menopause transition, pregnancy disorders, and other gynaecologic conditions: a consensus document from European cardiologists, gynaecologists, and endocrinologists. European Heart Journal 42:10, pages 967-984.
Crossref
O. L. Palladina. (2021) DIETARY POSSIBILITIES OF CORRECTION OF EATING DISORDERS IN PREMENOPAUSAL WOMEN. Bulletin of Problems Biology and Medicine 2:1, pages 115.
Crossref
Richard J Santen, Daniel F Heitjan, Anne Gompel, Mary Ann Lumsden, JoAnn V Pinkerton, Susan R Davis & Cynthia A Stuenkel. (2020) Approach to Managing a Postmenopausal Patient. The Journal of Clinical Endocrinology & Metabolism 105:12, pages 3792-3806.
Crossref
Cezary Chojnacki, Marta Mędrek-Socha, Paulina Konrad, Jan Chojnacki & Aleksandra Błońska. (2020) The value of melatonin supplementation in postmenopausal women with Helicobacter pylori-associated dyspepsia. BMC Women's Health 20:1.
Crossref
Sharanya Ramesh, Matthew T James, Jayna M Holroyd-Leduc, Stephen B Wilton, Ellen W Seely, Brenda R Hemmelgarn, Marcello Tonelli, David C Wheeler & Sofia B Ahmed. (2020) Estradiol and mortality in women with end-stage kidney disease. Nephrology Dialysis Transplantation 35:11, pages 1965-1972.
Crossref
О. О. Єфіменко & О. В. Занько. (2020) Menopause: focus on additional therapy opportunities. Literature review. REPRODUCTIVE ENDOCRINOLOGY:53, pages 62-68.
Crossref
M. S. Selikhova. (2020) Menopausal Therapy: Modern View of the Problem. Advances in Gerontology 10:3, pages 205-209.
Crossref
Cristina Llaneza-Suarez, Montserrat Eiriz-Eirin & Placido Llaneza. (2020) Arterial palmar arch occlusion in a woman with Raynaud's disease taking oral combined menopausal hormone therapy: A case report. Case Reports in Women's Health 27, pages e00206.
Crossref
Jennifer L Gordon, David R Rubinow, Lana Watkins, Alan L Hinderliter, Melissa C Caughey & Susan S Girdler. (2020) The Effect of Perimenopausal Transdermal Estradiol and Micronized Progesterone on Markers of Risk for Arterial Disease. The Journal of Clinical Endocrinology & Metabolism 105:5, pages e2050-e2060.
Crossref
L. Photiou, M.J. Lin, D.P. Dubin, V. Lenskaya & H. Khorasani. (2020) Review of non‐invasive vulvovaginal rejuvenation. Journal of the European Academy of Dermatology and Venereology 34:4, pages 716-726.
Crossref
Sonya S. Brady, Amanda Berry, Deepa R. Camenga, Colleen M. Fitzgerald, Sheila Gahagan, Cecilia T. Hardacker, Bernard L. Harlow, Jeni Hebert‐Beirne, D. Yvette LaCoursiere, Jessica B. Lewis, Lisa K. Low, Jerry L. Lowder, Alayne D. Markland, Gerald McGwin, Diane K. Newman, Mary H. Palmer, David A. Shoham, Ariana L. Smith, Ann Stapleton, Beverly R. Williams & Siobhan Sutcliffe. (2020) Applying concepts of life course theory and life course epidemiology to the study of bladder health and lower urinary tract symptoms among girls and women. Neurourology and Urodynamics 39:4, pages 1185-1202.
Crossref
О. О. Єфіменко. (2020) Menopause. A problem that is not out of date. Specialist comment and updated data from the National Consensus on the Management of Patients in Menopause. REPRODUCTIVE ENDOCRINOLOGY:51, pages 72-88.
Crossref
Peter Collins, Angela Maas, Megha Prasad, Louise Schierbeck & Amir Lerman. (2020) Endothelial Vascular Function as a Surrogate of Vascular Risk and Aging in Women. Mayo Clinic Proceedings 95:3, pages 541-553.
Crossref
Angelo Cagnacci, Marco Gambacciani, Mario Gallo & Stefano Lello. (2020) Recommendations on menopausal hormone replacement therapy. Minerva Ginecologica 71:6.
Crossref
Sa Ra LeeMoon Kyoung ChoYeon Jean ChoSungwook ChunSeung-Hwa HongKyu Ri HwangGyun-Ho JeonJong Kil JooSeul Ki KimDong Ock LeeDong-Yun LeeEun Sil LeeJae Yen SongKyong Wook YiBo Hyon YunJung-Ho ShinHee Dong Chae & Tak Kim. (2020) The 2020 Menopausal Hormone Therapy Guidelines. Journal of Menopausal Medicine 26:2, pages 69.
Crossref
V.E. Balan, E.V. Tikhomirova, Ya.Z. Zaidieva, E.V. Kruchinina, A.S. Zhuravel’, Yu.P. Titchenko, O.S. Fomina-Nilova & A.V. Tsar’kova. (2020) The changing shape of menopausal hormone therapy. Rossiiskii vestnik akushera-ginekologa 20:4, pages 95.
Crossref
Laura Gomes Lima, Najwa Munir Tayfour, Paula Cristina Oliveira Lemos, Maryanna Freitas Alves, Isadora Mota Ferreira & Eriston Vieira Gomes. (2020) Hormone Replacement Therapy: Risks and Benefits. Integrative Journal of Medical Sciences.
Crossref
Richard J. Santen, Sebastian Mirkin, Brian Bernick & Ginger D. Constantine. (2020) Systemic estradiol levels with low-dose vaginal estrogens. Menopause 27:3, pages 361-370.
Crossref
А. В. Гурандо, О. О. Єфіменко & І. М. Ретунська. (2019) Sclerosis of the mammary arteries in perimenopausal women as an early marker of atherosclerosis. Reproductive Endocrinology 0:50, pages 66-69.
Crossref
О. О. Єфіменко, В. В. Дунаєвська & І. М. Ретунська. (2019) Current antimicrobial therapy of infectious complications of genitourinary syndrome in perimenopausal women. Reproductive Endocrinology 0:50, pages 43-46.
Crossref
Petra Stute. (2019) Bioidentische HormoneHormones Bio-Identiques. Journal für Gynäkologische Endokrinologie/Schweiz 22:4, pages 152-155.
Crossref
Ginger Constantine, Leah S. Millheiser, Andrew M. Kaunitz, Sharon J. Parish, Shelli GrahamBrian BernickSebastian Mirkin. (2019) Early onset of action with a 17β-estradiol, softgel, vaginal insert for treating vulvar and vaginal atrophy and moderate to severe dyspareunia. Menopause 26:11, pages 1259-1264.
Crossref
Ayesha A. Javed, Alexandra J. Mayhew, Alison K. Shea & Parminder Raina. (2019) Association Between Hormone Therapy and Muscle Mass in Postmenopausal Women. JAMA Network Open 2:8, pages e1910154.
Crossref
Ю. П. Вдовиченко, О. О. Єфіменко, Н. Ю. Педаченко & О. І. Яцина. (2019) Differentiated approach to the treatment of genitourinary syndrome in perimenopausal women. Reproductive Endocrinology 0:46, pages 8-18.
Crossref
Wolfgang BrozekGabriele NagelHanno UlmerHans Concin. (2019) Bone Mineral Density and Breast Cancer Incidence and Mortality in Postmenopausal Women: A Long-Term Follow-Up Study. Journal of Women's Health 28:5, pages 628-635.
Crossref
Lotta Lindh-Åstrand, Mikael Hoffmann, Mats Fredrikson, Mats Hammar & Anna-Clara Spetz Holm. (2019) Use of hormone therapy (HT) among Swedish women with contraindications – A pharmacoepidemiological cohort study. Maturitas 123, pages 55-60.
Crossref
L. Vignozzi, N. Malavolta, P. Villa, G. Mangili, S. Migliaccio & S. Lello. (2018) Consensus statement on the use of HRT in postmenopausal women in the management of osteoporosis by SIE, SIOMMMS and SIGO. Journal of Endocrinological Investigation 42:5, pages 609-618.
Crossref
T. M. Sokolova, I. O. Marinkin, V. M. Кuleshov & K. Yu. Makarov. (2019) Experience of using MHT combined with dipyridamole in patients in the early postmenopause. Medical Council:6, pages 130-134.
Crossref
Ya. Z. Zaydieva. (2019) Menopausal hormone therapy and cancer risks of reproductive system. Literature review. Medical alphabet 1:1, pages 42-50.
Crossref
Dae-Hui Kwon & Jung-Ho Shin. (2019) Updated treatment guideline for hormone therapy in postmenopausal women. Journal of the Korean Medical Association 62:3, pages 145.
Crossref
Santiago Palacios, John C Stevenson, Katrin Schaudig, Monika Lukasiewicz & Alessandra Graziottin. (2019) Hormone therapy for first-line management of menopausal symptoms: Practical recommendations. Women's Health 15, pages 174550651986400.
Crossref
S.E. Segerer & C. Keck. 2019. Therapie-Handbuch. Therapie-Handbuch 309 313 .
Marie-Cécile Valéra, Coralie Fontaine, Emmanuelle Noirrit-Esclassan, Frédéric Boudou, Melissa Buscato, Marine Adlanmerini, Florence Trémollières, Pierre Gourdy, Françoise Lenfant & Jean-François Arnal. (2019) Vers une optimisation de la modulation du récepteur des œstrogènes dans le traitement hormonal de la ménopause. médecine/sciences 34:12, pages 1056-1062.
Crossref
Pragya Gartoulla, Roisin Worsley, Robin J. Bell & Susan R. Davis. (2018) Moderate to severe vasomotor and sexual symptoms remain problematic for women aged 60 to 65 years. Menopause 25:11, pages 1331-1338.
Crossref
Marie-Cécile Valéra, Coralie Fontaine, Marion Dupuis, Emmanuelle Noirrit-Esclassan, Alexia Vinel, Maeva Guillaume, Pierre Gourdy, Françoise Lenfant & Jean-François Arnal. (2018) Towards optimization of estrogen receptor modulation in medicine. Pharmacology & Therapeutics 189, pages 123-129.
Crossref
Sharon J. Parish, Rossella E. Nappi & Sheryl Kingsberg. (2018) Perspectives on counseling patients about menopausal hormone therapy: strategies in a complex data environment. Menopause 25:8, pages 937-949.
Crossref
S. N. Tolstov, I. A. Salov & A. P. Rebrov. (2018) CHANGES OF CARDIOMETABOLIC RISK FACTORS IN EARLY AND LONG-TERM USE OF MENOPAUZAL HORMONE THERAPY IN WOMEN OF THE CLIMACTERIC PERIOD. Siberian Medical Journal 33:2, pages 56-63.
Crossref
Sofia B. Ahmed & Sandra M. Dumanski. (2018) Postmenopausal hormone therapy and the kidney: a new target for an old treatment?. Menopause 25:6, pages 591-593.
Crossref
Tiziana Pagano, Pasquale De Rosa, Roberta Vallone, Francesco SchettiniGrazia ArpinoMario GiulianoRossella LauriaIrene De SantoAlessandro Conforti, Alessandra Gallo, Giovanni Nazzaro, Sabino De PlacidoMariavittoria Locci & Giuseppe De Placido. (2018) Fractional microablative CO2 laser in breast cancer survivors affected by iatrogenic vulvovaginal atrophy after failure of nonestrogenic local treatments: a retrospective study. Menopause 25:6, pages 657-662.
Crossref
Susan R. Davis. (2018) Androgens in postmenopausal womenAndrogene bei Frauen in der Postmenopause. Gynäkologische Endokrinologie 16:2, pages 123-127.
Crossref
Hai Jiang, Wenpei Bai, Wenjuan Wang, Ke Wang, Jing Jia, Jing Zhang, He Diao & Lihua Qin. (2018) Proteomics in plasma of ovariectomized rats and those exposed to estradiol valerate. The Journal of Steroid Biochemistry and Molecular Biology 178, pages 1-12.
Crossref
N. Biglia, V.E. Bounous, T. Susini, S. Pecchio, L.G. Sgro, V. Tuninetti & R. Torta. (2018) Duloxetine and escitalopram for hot flushes: efficacy and compliance in breast cancer survivors. European Journal of Cancer Care 27:1, pages e12484.
Crossref
Rifani B. Natari, Alexandra M. Clavarino, Treasure M. McGuire, Kaeleen D. DingleSamantha A. Hollingworth. (2018) The bidirectional relationship between vasomotor symptoms and depression across the menopausal transition: a systematic review of longitudinal studies. Menopause 25:1, pages 109-120.
Crossref
S.E. Segerer & C. Keck. 2018. Therapie-Handbuch. Therapie-Handbuch 595 599 .
Piero Sismondi, Valentina Elisabetta Bounous, Valentina Tuninetti, Viola Liberale, Martina Gallo & Nicoletta Biglia. 2018. Pre-Menopause, Menopause and Beyond. Pre-Menopause, Menopause and Beyond 223 232 .
Piero Sismondi, Marta D’Alonzo, Paola Modaffari, Viola Liberale, Valentina Elisabetta Bounous, Andrea Villasco & Nicoletta Biglia. 2018. Pre-Menopause, Menopause and Beyond. Pre-Menopause, Menopause and Beyond 205 213 .
Sandra M. Dumanski, Sharanya Ramesh, Matthew T. James, Amy Metcalfe, Kara Nerenberg, Ellen W. Seely, Helen Lee Robertson & Sofia B. Ahmed. (2017) The effect and safety of postmenopausal hormone therapy and selective estrogen receptor modulators on kidney outcomes in women: a protocol for systematic review and meta-analysis. Systematic Reviews 6:1.
Crossref
JoAnn V. Pinkerton, Andrew G. Bushmakin, Joel Bobula, Joanne Lavenberg, Barry S. Komm & Lucy Abraham. (2017) Hot flush frequency and severity at baseline as predictors of time to transient and stable treatment success: pooled analysis of two CE/BZA studies. Menopause 24:12, pages 1378-1385.
Crossref
Nicoletta Biglia, Valentina Elisabetta Bounous, Marta D'Alonzo, Laura Ottino, Valentina Tuninetti, Elisabetta Robba & Tania Perrone. (2017) Vaginal Atrophy in Breast Cancer Survivors: Attitude and Approaches Among Oncologists. Clinical Breast Cancer 17:8, pages 611-617.
Crossref
Mélisa Audet, Alex Dumas, Rachelle Binette & Isabelle J. Dionne. (2017) Women, weight, poverty and menopause: understanding health practices in a context of chronic disease prevention. Sociology of Health & Illness 39:8, pages 1412-1426.
Crossref
Jasmin Grigg, Roisin Worsley, Caroline Thew, Caroline Gurvich, Natalie Thomas & Jayashri Kulkarni. (2017) Antipsychotic-induced hyperprolactinemia: synthesis of world-wide guidelines and integrated recommendations for assessment, management and future research. Psychopharmacology 234:22, pages 3279-3297.
Crossref
Alexander Römmler. (2017) Bioidentische Hormone in der MenopausetherapieHormones bio-identiques dans le traitement de la ménopause. Journal für Gynäkologische Endokrinologie/Schweiz 20:3, pages 102-108.
Crossref
Alexander Römmler. (2017) Bioidentische Hormone in der MenopausetherapieBioidentical hormones in menopausal therapy. Journal für Gynäkologische Endokrinologie/Österreich 27:3, pages 95-101.
Crossref
Mélisa Audet, Alex Dumas, Rachelle Binette & Isabelle J. Dionne. (2017) Lifestyle Inequalities: Explaining Socioeconomic Differences in Preventive Practices of Clinically Overweight Women After Menopause. Qualitative Health Research 27:10, pages 1541-1552.
Crossref
Sofia B. Ahmed. (2017) Menopause and Chronic Kidney Disease. Seminars in Nephrology 37:4, pages 404-411.
Crossref
Albe C. Swanepoel, Priyaa Naidoo, Vance G. Nielsen & Etheresia Pretorius. (2017) Clinical relevance of hypercoagulability and possible hypofibrinolysis associated with estrone and estriol. Microscopy Research and Technique 80:7, pages 697-703.
Crossref
Marco Gambacciani & Santiago Palacios. (2017) Laser therapy for the restoration of vaginal function. Maturitas 99, pages 10-15.
Crossref
Mariana S. SousaMichelle Peate, Sherin Jarvis, Martha Hickey & Michael Friedlander. (2017) A clinical guide to the management of genitourinary symptoms in breast cancer survivors on endocrine therapy. Therapeutic Advances in Medical Oncology 9:4, pages 269-285.
Crossref
Ginger D. Constantine, James A. Simon, James H. Pickar, David F. Archer, Harvey Kushner, Brian BernickGina GasperShelli GrahamSebastian Mirkin. (2017) The REJOICE trial: a phase 3 randomized, controlled trial evaluating the safety and efficacy of a novel vaginal estradiol soft-gel capsule for symptomatic vulvar and vaginal atrophy. Menopause 24:4, pages 409-416.
Crossref
Marco Gambacciani & Marco Levancini. (2017) Vaginal erbium laser as second-generation thermotherapy for the genitourinary syndrome of menopause: a pilot study in breast cancer survivors. Menopause 24:3, pages 316-319.
Crossref
Emily A. Southmayd & Mary Jane De Souza. (2017) A summary of the influence of exogenous estrogen administration across the lifespan on the GH/IGF-1 axis and implications for bone health. Growth Hormone & IGF Research 32, pages 2-13.
Crossref
Bo Ra ParkHye Na ParkJi Back JungEun Sil Lee, Jeong Sig KimGyu Yeon ChoiJeong Jae LeeIm Soon Lee. (2017) Efficacy and safety of drospirenone 2 mg/17β-estradiol 1 mg hormone therapy in Korean postmenopausal women. Obstetrics & Gynecology Science 60:2, pages 213.
Crossref
Isabella Pagano, Stefania Gieri, Francesca Nocera, Giuseppe Scibilia, Filippo Fraggetta, Antonio Galia, Mauro Gioè, Basilio Pecorino & Paolo Scollo. (2017) Evaluation of the CO<sub>2</sub> Laser Therapy on Vulvo-Vaginal Atrophy (VVA) in Oncological Patients: Preliminary Results. Journal of Cancer Therapy 08:05, pages 452-463.
Crossref
Petra Stute, Gunnar Habermann, Ludwig Kiesel, Hans-Heinrich Henneicke-von Zepelin & Susana Garcia de Arriba. (2016) Effects of black cohosh on estrogen biosynthesis in hippocampus of non-human primates ex vivo in vitro and in human neuroblastoma cells in vitro. Clinical Phytoscience 2:1.
Crossref
Sharanya Ramesh, Matthew T. James, Jayna M. Holroyd-Leduc, Stephen B. Wilton, Ellen W. Seely, David C. Wheeler & Sofia B. Ahmed. (2017) Sex Hormone Status in Women With Chronic Kidney Disease: Survey of Nephrologists’ and Renal Allied Health Care Providers’ Perceptions. Canadian Journal of Kidney Health and Disease 4, pages 205435811773453.
Crossref
Gary Hattersley, Alan G. Harris, James A. Simon & Ginger D. Constantine. (2017) Clinical investigation of RAD1901, a novel estrogen receptor ligand, for the treatment of postmenopausal vasomotor symptoms: a phase 2 randomized, placebo-controlled, double-blind, dose-ranging, proof-of-concept trial. Menopause 24:1, pages 92-99.
Crossref
Henny Lukman, Amanda Hillard & Timothy Hillard. 2017. Women's Health in Primary Care. Women's Health in Primary Care 119 123 .
David W. Sturdee. 2017. International Encyclopedia of Public Health. International Encyclopedia of Public Health 26 34 .
Raja Sayegh & Johnny T. Awwad. 2017. Essentials of Menopause Management. Essentials of Menopause Management 13 43 .
V. E. Balan, A. S. Zhuravel, O. V. Lopatina & S. A. Orlova. (2016) Evolution of menopausal hormone therapy: from standard to ultra-low doses. Medical Council:2, pages 74-78.
Crossref
Marco Gambacciani & Renato Pasquali. (2017) Hot flushes e sudorazione eccessiva menopausale: strategie terapeutiche. L'Endocrinologo 17:6, pages 317-318.
Crossref
Ginger D Constantine, Shelli Graham, Cathy Clerinx, Brian A Bernick, Mitchell Krassan, Sebastian Mirkin & Heather Currie. (2016) Behaviours and attitudes influencing treatment decisions for menopausal symptoms in five European countries. Post Reproductive Health 22:3, pages 112-122.
Crossref
Sharanya Ramesh, Michelle C. Mann, Jayna M. Holroyd-Leduc, Stephen B. Wilton, Matthew T. James, Ellen W. SeelySofia B. Ahmed. (2016) Hormone therapy and clinical and surrogate cardiovascular endpoints in women with chronic kidney disease: a systematic review and meta-analysis. Menopause 23:9, pages 1028-1037.
Crossref
Ioannis Kyvernitakis & Peyman Hadji. (2016) Postmenopausale OsteoporosePostmenopausal osteoporosis. Gynäkologische Endokrinologie 14:3, pages 197-207.
Crossref
James H. Pickar, Julia M. Amadio, John M. Hill, Brian A. Bernick & Sebastian Mirkin. (2016) A randomized, double-blind, placebo-controlled phase 2 pilot trial evaluating a novel, vaginal softgel capsule containing solubilized estradiol. Menopause 23:5, pages 506-510.
Crossref
Holli A. DeVon, Christina M. Pettey, Karen M. Vuckovic, Mary Dawn Koenig & Jean C. McSweeney. (2016) A Review of the Literature on Cardiac Symptoms in Older and Younger Women. Journal of Obstetric, Gynecologic & Neonatal Nursing 45:3, pages 426-437.
Crossref
J. M. Wenderlein. (2016) Primärprävention des Diabetes mellitus Typ 2Primary prevention of type 2 diabetes mellitus. Gynäkologische Endokrinologie 14:2, pages 142-148.
Crossref
Ignacio Zapardiel, Maria Cruz, Maria D. Diestro, Antonio Requena & Juan A. Garcia-Velasco. (2016) Assisted reproductive techniques after fertility-sparing treatments in gynaecological cancers. Human Reproduction Update 22:3, pages 281-305.
Crossref
Swan Sim Yeap, Fen Lee Hew, Premitha Damodaran, Winnie Chee, Joon Kiong Lee, Emily Man Lee Goh, Malik Mumtaz, Heng Hing Lim & Siew Pheng Chan. (2016) A summary of the Malaysian Clinical Guidance on the management of postmenopausal and male osteoporosis, 2015. Osteoporosis and Sarcopenia 2:1, pages 1-12.
Crossref
JoAnn V. Pinkerton & James H. Pickar. (2016) Update on medical and regulatory issues pertaining to compounded and FDA-approved drugs, including hormone therapy. Menopause 23:2, pages 215-223.
Crossref
Katrin Schaudig & Anneliese Schwenkhagen. (2016) Individualisierte Hormontherapie in Peri- und PostmenopauseIndividualized hormone therapy in the peri- and postmenopausal period. Gynäkologische Endokrinologie 14:1, pages 31-43.
Crossref
Petra Stute. (2015) Tod durch Absetzen einer Hormonersatztherapie?Death after discontinuing hormone replacement therapy?. Gynäkologische Endokrinologie 14:1, pages 54-55.
Crossref
Ya. Z. Zaidieva. (2016) Menopausal hormone therapy: a risk for reproductive system cancer and its recurrences. Rossiiskii vestnik akushera-ginekologa 16:6, pages 105.
Crossref
L. M. Il'ina, S. V. Yureneva, A. V. Dubrovina & Z. H. Jebzieva. (2016) The influence of menopause on life of working women: the problem without necessary attention. Problemy reproduktsii 22:1, pages 87.
Crossref
S. V. Yureneva & L. M. Il'ina. (2016) LNG-IUS for helping a doctor during the most difficult period of women’s reproductive aging. Problemy reproduktsii 22:1, pages 79.
Crossref
Roisin Worsley, Robin J. Bell, Pragya Gartoulla & Susan R. Davis. (2016) Low use of effective and safe therapies for moderate to severe menopausal symptoms. Menopause 23:1, pages 11-17.
Crossref
Andrea Giannini, Andrea R. Genazzani & Tommaso Simoncini. 2016. Frontiers in Gynecological Endocrinology. Frontiers in Gynecological Endocrinology 61 66 .
Nicholas Panay. 2016. Frontiers in Gynecological Endocrinology. Frontiers in Gynecological Endocrinology 53 59 .
Nicholas Panay. 2016. Frontiers in Gynecological Endocrinology. Frontiers in Gynecological Endocrinology 203 208 .
Andrea Giannini, Andrea R. Genazzani & Tommaso Simoncini. 2016. Frontiers in Gynecological Endocrinology. Frontiers in Gynecological Endocrinology 161 168 .
Susan R. Davis, Irene Lambrinoudaki, Maryann Lumsden, Gita D. Mishra, Lubna Pal, Margaret Rees, Nanette Santoro & Tommaso Simoncini. (2015) Menopause. Nature Reviews Disease Primers 1:1.
Crossref
Jerilynn C. Prior. (2015) Progesterone or progestin as menopausal ovarian hormone therapy. Current Opinion in Endocrinology, Diabetes & Obesity 22:6, pages 495-501.
Crossref
James H. Pickar, Charles Bon, Julia M. Amadio, Sebastian Mirkin & Brian Bernick. (2015) Pharmacokinetics of the first combination 17β-estradiol/progesterone capsule in clinical development for menopausal hormone therapy. Menopause 22:12, pages 1308-1316.
Crossref
Nicoletta Biglia, Valentina E. Bounous, Luca G. Sgro, Marta D'Alonzo, Silvia Pecchio & Rossella E. Nappi. (2015) Genitourinary Syndrome of Menopause in Breast Cancer Survivors: Are We Facing New and Safe Hopes?. Clinical Breast Cancer 15:6, pages 413-420.
Crossref
Yuko Morii, Hiroshi Matsushita, Akira Minami, Hiroaki Kanazawa, Takashi Suzuki, Sanan Subhadhirasakul, Kazushi Watanabe & Akihiko Wakatsuki. (2015) Young Coconut Juice Supplementation Results in Greater Bone Mass and Bone Formation Indices in Ovariectomized Rats: A Preliminary Study. Phytotherapy Research 29:12, pages 1950-1955.
Crossref
M. Birkhäuser. (2015) Menopausale Hormontherapie und koronare HerzkrankheitMenopausal hormone therapy and cardiovascular disease. Gynäkologische Endokrinologie 13:4, pages 257-265.
Crossref
Alfred O. Mueck. (2015) Anwendungsempfehlungen zur Hormonsubstitution in Klimakterium und PostmenopauseRecommendations for use of hormone replacement in menopause and postmenopause. Gynäkologische Endokrinologie 13:4, pages 270-273.
Crossref
JoAnn V. Pinkerton & Nanette Santoro. (2015) Compounded bioidentical hormone therapy. Menopause 22:9, pages 926-936.
Crossref
Marco Gambacciani & Marco Levancini. (2015) Rivisitazione della terapia sostitutiva in postmenopausa alla luce dei risultati dei grandi trials. L'Endocrinologo 16:4, pages 135-140.
Crossref
M. Birkhäuser. (2015) Menopausale Hormontherapie zur FrakturpräventionMenopausal hormone therapy for fracture prevention. Gynäkologische Endokrinologie 13:3, pages 188-194.
Crossref
Nick Panay. 2015. Managing the Menopause. Managing the Menopause 215 222 .
Luiza Hoga, Juliana Rodolpho, Bruna Gonçalves & Bruna Quirino. (2015) Womenʼs experience of menopause: a systematic review of qualitative evidence. JBI Database of Systematic Reviews and Implementation Reports 13:8, pages 250-337.
Crossref
Pragya Gartoulla, Roisin Worsley, Robin J. Bell & Susan R. Davis. (2015) Moderate to severe vasomotor and sexual symptoms remain problematic for women aged 60 to 65 years. Menopause 22:7, pages 694-701.
Crossref
F. Boudghène, P. Gautier, P. Delsart, G. Claisse, B. Letombe, P. Fayolle, P. Devos & C. Mounier Vehier. (2015) Le circuit « cœur, artères et femmes » chez la femme à haut risque cardiovasculaire : première évaluation à un an. Annales de Cardiologie et d'Angéiologie 64:3, pages 199-204.
Crossref
. (2015) Menopausal hormone use and ovarian cancer risk: individual participant meta-analysis of 52 epidemiological studies. The Lancet 385:9980, pages 1835-1842.
Crossref
J. Liu, H. Lin, Y. Huang, Y. Liu, B. Wang & F. Su. (2015) Cognitive effects of long-term dydrogesterone treatment used alone or with estrogen on rat menopausal models of different ages. Neuroscience 290, pages 103-114.
Crossref
Santiago Palacios, Heather Currie, Tomi S. Mikkola & Erika Dragon. (2015) Perspective on prescribing conjugated estrogens/bazedoxifene for estrogen-deficiency symptoms of menopause: A practical guide. Maturitas 80:4, pages 435-440.
Crossref
Régine Sitruk-Ware. (2015) Œstrogènes, traitement hormonal, et vieillissement. Bulletin de l'Académie Nationale de Médecine 199:2-3, pages 355-362.
Crossref
M. Birkhäuser & T. Strowitzki. (2015) Knochen und GelenkeBones and joints. Gynäkologische Endokrinologie 13:1, pages 5-6.
Crossref
A.O. Mueck. (2015) Systemische Progesterontherapie – transdermal?Systemic progesterone therapy – transdermal?. Gynäkologische Endokrinologie 13:1, pages 50-56.
Crossref
Ewa Walecka-Kapica, Jan Chojnacki, Agnieszka Stępień, Patrycja Wachowska-Kelly, Grażyna Klupińska & Cezary Chojnacki. (2015) Melatonin and Female Hormone Secretion in Postmenopausal Overweight Women. International Journal of Molecular Sciences 16:1, pages 1030-1042.
Crossref
Soo Ah KimHyuk Jung. (2015) Prevention of Cognitive Impairment in the Midlife Women. Journal of Menopausal Medicine 21:1, pages 19.
Crossref
Penelope M Webb. (2015) Environmental (nongenetic) factors in gynecological cancers: update and future perspectives. Future Oncology 11:2, pages 295-307.
Crossref
L. A. Nikolenko, D. I. Alekhin & E. S. Nikolenko. (2015) Postmenopause, metabolic syndrome and coronary heart disease (a review). Problemy reproduktsii 21:3, pages 117.
Crossref
Shagaf H Bakour & Jennifer Williamson. (2014) Latest evidence on using hormone replacement therapy in the menopause. The Obstetrician & Gynaecologist 17:1, pages 20-28.
Crossref
Sabine Elisabeth Segerer & Christoph Keck. 2015. Therapie-Handbuch Grundwerk inkl 6. Lfg.. Therapie-Handbuch Grundwerk inkl 6. Lfg. 1 5 .
Sheila O'Neill & John Eden. (2014) The pathophysiology of menopausal symptoms. Obstetrics, Gynaecology & Reproductive Medicine 24:12, pages 349-356.
Crossref
René Rizzoli. (2014) Nutritional aspects of bone health. Best Practice & Research Clinical Endocrinology & Metabolism 28:6, pages 795-808.
Crossref
Xiangyan Ruan & Alfred.O. Mueck. (2014) Systemic progesterone therapy—Oral, vaginal, injections and even transdermal?. Maturitas 79:3, pages 248-255.
Crossref

Displaying 200 of 220 citing articles. Use the download link below to view the full list of citing articles.

Download full citations list

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.